MICHELLE BUDNICK: Open Payments
NPI 1679636583 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 21 payments from 9 companies in 2025. Trend: 2023 $368 · 2024 $366 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $138 |
| Amgen Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Galderma Laboratories, L.P. | 2 | $30 |
| UCB, Inc. | 1 | $30 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Biofrontera Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: SKYRIZI, OTEZLA, LIBTAYO, BOTOX, NEMLUVIO, Bimzelx, YCANTH, AMELUZ.
Industry payments across FL — which companies pay providers there.
